TY - JOUR
T1 - OX40 costimulation turns off Foxp3+ Tregs
AU - Vu, Minh Diem
AU - Xiao, Xiang
AU - Gao, Wenda
AU - Degauque, Nicolas
AU - Chen, Ming
AU - Kroemer, Alexander
AU - Killeen, Nigel
AU - Ishii, Naoto
AU - Li, Xian Chang
N1 - Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2007/10/1
Y1 - 2007/10/1
N2 - OX40 is a recently identified T-cell costimulatory molecule that belongs to the TNF/TNFR superfamily. OX40 can be expressed by both activated T effector cells and Foxp3 + Tregs. It is well known that OX40 delivers a potent costimulatory signal to T effector cells, but very little is known about the role of OX40 in regulating the suppressor properties of Foxp3 + Tregs and the de novo generation of new inducible Foxp3 + Tregs from T effector cells. In the present study, we found, by using a newly created foxp3gfp knockin model, that OX40 was dispensable for the genesis and suppressor functions of naturally arising CD4 +Foxp3 + Tregs, but stimulating OX40 on the Foxp + Tregs abrogated their ability to suppress T effector cell proliferation, IFN-γ production, and T effector cell-mediated allograft rejection. OX40 costimulation did not signifi-cantly affect proliferation and survival of the naturally arising Foxp3 + Tregs, but profoundly inhibited Foxp3 gene expression. Importantly, OX40 costimulation to T effector cells prevented the induction of new inducible Foxp3 + Tregs from T effector cells. Our study identified OX40 as a key negative regulator of Foxp3 + Tregs and may have important clinical implications in models of transplantation and autoimmunity.
AB - OX40 is a recently identified T-cell costimulatory molecule that belongs to the TNF/TNFR superfamily. OX40 can be expressed by both activated T effector cells and Foxp3 + Tregs. It is well known that OX40 delivers a potent costimulatory signal to T effector cells, but very little is known about the role of OX40 in regulating the suppressor properties of Foxp3 + Tregs and the de novo generation of new inducible Foxp3 + Tregs from T effector cells. In the present study, we found, by using a newly created foxp3gfp knockin model, that OX40 was dispensable for the genesis and suppressor functions of naturally arising CD4 +Foxp3 + Tregs, but stimulating OX40 on the Foxp + Tregs abrogated their ability to suppress T effector cell proliferation, IFN-γ production, and T effector cell-mediated allograft rejection. OX40 costimulation did not signifi-cantly affect proliferation and survival of the naturally arising Foxp3 + Tregs, but profoundly inhibited Foxp3 gene expression. Importantly, OX40 costimulation to T effector cells prevented the induction of new inducible Foxp3 + Tregs from T effector cells. Our study identified OX40 as a key negative regulator of Foxp3 + Tregs and may have important clinical implications in models of transplantation and autoimmunity.
UR - http://www.scopus.com/inward/record.url?scp=34948883517&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34948883517&partnerID=8YFLogxK
U2 - 10.1182/blood-2007-01-070748
DO - 10.1182/blood-2007-01-070748
M3 - Article
C2 - 17575071
AN - SCOPUS:34948883517
SN - 0006-4971
VL - 110
SP - 2501
EP - 2510
JO - Blood
JF - Blood
IS - 7
ER -